STOCK TITAN

United Therapeutics (NASDAQ: UTHR) proposed sale of 1,300 shares via option

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

United Therapeutics Corporation submitted a Form 144 notice to sell 1,300 shares of Common Stock via a stock option exercise to be effected on 03/30/2026. The filing lists prior open-market dispositions by Christopher Causey totaling multiple transactions in January–March 2026.

Positive

  • None.

Negative

  • None.
Proposed sale 1,300 shares Stock Option Exercise on 03/30/2026
Recent sale 20 shares Sold 03/04/2026 for $9,803.37
Recent sale 1,000 shares Sold 02/25/2026 for $520,000.00
Recent sale 1,000 shares Sold 01/06/2026 for $510,000.00
Recent sale 1,000 shares Sold 01/02/2026 for $500,014.60
Form 144 regulatory
"submitted a Form 144 notice to sell 1,300 shares"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Stock Option Exercise financial
"03/30/2026 | Stock Option Exercise | Issuer"
A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.
Issuer regulatory
"Stock Option Exercise | Issuer | ... | 1300"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does UTHR's Form 144 say about the sale?

It notifies of a proposed sale of 1,300 shares by way of a stock option exercise on 03/30/2026. The filing is a regulatory notice of intent to sell; actual settlement depends on the transaction taking place as described.

Who is the selling party named in the Form 144 for UTHR?

The filing identifies transactions by Christopher Causey in the past three months and lists the proposed sale tied to the issuer. Christopher Causey appears in the recent dispositions section with multiple dated sales and dollar amounts.

How large are the recent transactions disclosed in the filing?

The Form 144 shows a proposed sale of 1,300 shares on 03/30/2026. It also records prior sales: 20 shares for $9,803.37 and three separate 1,000-share sales with values of $520,000, $510,000, and $500,014.60.

What method of transaction is listed for the 1,300 shares in UTHR's Form 144?

The 1,300-share sale is described as a Stock Option Exercise with the method shown as Cash. The filing lists the seller category as Issuer, indicating the exercise is being processed through the company.

Does the Form 144 state who receives proceeds from the sale?

The filing lists the transaction method as Cash and labels the party as Issuer. It therefore indicates cash proceeds flow in connection with an issuer stock option exercise as described in the notice.
United Therapeutics Corp.

NASDAQ:UTHR

View UTHR Stock Overview

UTHR Rankings

UTHR Latest News

UTHR Latest SEC Filings

UTHR Stock Data

25.79B
42.87M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
SILVER SPRING